tiprankstipranks
Advertisement

EVUS - ETF AI Analysis

Compare

Top Page

EVUS

iShares ESG Aware MSCI USA Value ETF (EVUS)

Rating:73Outperform
Price Target:
EVUS, the iShares ESG Aware MSCI USA Value ETF, earns a solid overall rating largely because its biggest positions in financially strong, growth-focused companies like Microsoft and Micron provide long-term support through leadership in cloud, AI, and advanced memory technologies. Additional holdings such as Cisco and Johnson & Johnson add stability and diversification, while weaker names like Intel and AbbVie, which face valuation and profitability challenges, modestly weigh on the fund’s appeal. The main risk factor is its meaningful exposure to a handful of large technology and AI-related companies, which can increase sensitivity to that sector’s ups and downs.
Positive Factors
Solid Recent Performance
The ETF has delivered strong gains so far this year and over the past few months, indicating positive recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors, including technology, financials, health care, and industrials, which helps reduce the impact of weakness in any single industry.
Reasonable Expense Ratio
The fund’s expense ratio is relatively low for an actively chosen theme, allowing investors to keep more of their returns over time.
Negative Factors
Heavy U.S.-Only Focus
Almost all assets are invested in U.S. companies, offering little geographic diversification if the U.S. market faces a downturn.
Concentration in Technology and Financials
A large share of the portfolio is in technology and financial stocks, which can increase risk if these sectors experience a pullback.
Weakness in Some Top Tech Holdings
Key positions like Microsoft and Meta have shown weak performance this year, which can drag on overall fund returns if the trend continues.

EVUS vs. SPDR S&P 500 ETF (SPY)

EVUS Summary

The iShares ESG Aware MSCI USA Value ETF (EVUS) tracks the MSCI USA Value Extended ESG Focus Index, which focuses on U.S. companies that look undervalued and also score well on environmental, social, and governance (ESG) measures. It holds many well-known names like Microsoft and Meta Platforms, along with banks, healthcare firms, and energy companies, giving investors broad exposure to the U.S. stock market with an ESG tilt. Someone might invest in EVUS for diversification and potential long-term growth while aligning with their values. A key risk is that its stock prices can go up and down with the overall market and value-style stocks.
How much will it cost me?The iShares ESG Aware MSCI USA Value ETF (EVUS) has an expense ratio of 0.18%, which means you’ll pay $1.80 per year for every $1,000 invested. This is lower than average for actively managed funds, as EVUS is passively managed to track an index, keeping costs down while focusing on ESG and value investing.
What would affect this ETF?The EVUS ETF, with its focus on U.S. value stocks and ESG criteria, could benefit from increased investor interest in sustainable investing and a potential rebound in undervalued sectors like financials and health care. However, it may face challenges from rising interest rates, which could impact financial stocks, and regulatory changes affecting ESG-focused investments. Additionally, its reliance on U.S. markets means it is sensitive to domestic economic conditions and policy shifts.

EVUS Top 10 Holdings

EVUS leans heavily into U.S. value names with a tech and financials tilt, and a few big positions are setting the tone. Microsoft and Meta have been mixed, with recent rebounds but still losing steam over the year, so they’re not the main engines of performance. Instead, Micron and Intel are doing more of the heavy lifting, riding strong momentum tied to AI and chips despite some bumps. JPMorgan and Exxon add steady, rising support from banks and energy, giving the fund a diversified but clearly U.S.-centric, value-flavored backbone.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Microsoft8.94%$34.19M$3.59T-4.73%
79
Outperform
Meta Platforms3.23%$12.35M$1.40T-27.14%
76
Outperform
Micron3.04%$11.62M$1.09T721.53%
79
Outperform
JPMorgan Chase2.65%$10.12M$934.57B18.68%
72
Outperform
Exxon Mobil1.60%$6.12M$678.92B48.37%
74
Outperform
AbbVie1.53%$5.86M$468.22B25.81%
66
Neutral
Johnson & Johnson1.52%$5.80M$651.25B50.73%
78
Outperform
Cisco Systems1.46%$5.59M$437.66B64.94%
77
Outperform
Intel1.25%$4.79M$473.28B263.18%
64
Neutral
Coca-Cola1.21%$4.64M$391.96B29.90%
75
Outperform

EVUS Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
35.90
Positive
100DMA
34.93
Positive
200DMA
33.57
Positive
Market Momentum
MACD
0.38
Positive
RSI
61.96
Neutral
STOCH
24.40
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EVUS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.75, equal to the 50-day MA of 35.90, and equal to the 200-day MA of 33.57, indicating a bullish trend. The MACD of 0.38 indicates Positive momentum. The RSI at 61.96 is Neutral, neither overbought nor oversold. The STOCH value of 24.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EVUS.

EVUS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$380.63M0.18%
73
Outperform
$944.66M0.13%
69
Neutral
$776.74M0.12%
71
Outperform
$664.44M0.40%
74
Outperform
$625.82M0.28%
72
Outperform
$429.19M0.38%
72
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EVUS
iShares ESG Aware MSCI USA Value ETF
37.08
6.59
21.61%
VFVA
Vanguard U.S. Value Factor ETF
VLU
SPDR S&P 1500 Value Tilt ETF
LSVD
LSV Disciplined Value ETF
QVAL
Alpha Architect U.S. Quantitative Value ETF
AIVL
WisdomTree U.S. AI Enhanced Value Fund
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement